RNN

Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
These are nine stocks trading under $10 a share have gains of 100% or more so far in 2017 — and some were up over 200% and 300%.
The top analyst upgrades, downgrades and initiations seen on Thursday include AMD, Panera, SeaWorld, T-Mobile, Walgreens and 8Point3.
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
Today’s version of the BioHealth Business Daily is again full of stocks on the move with news, and some not on news.  Array BioPharma, Inc. (NASDAQ: ARRY), BioDelivery Services International...
Today’s version of the BioHealth Business Daily has many stocks moving on news, but oddly many of the real news stocks are hardly moving and were eliminated from today’s report. ...
We are seeing many news-related movers in today’s edition of the BioHealth Business Daily.  ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona Pharmaceuticals, Inc. (AMEX: AEN), Dendreon...
There are more recognized stocks in today’s edition of the BioHealth Business Daily.  We are seeing significant and unusual moves, or implications, in shares of Celgene Corporation (NASDAQ: CELG),...
Today’s version of the BioHealth Business Daily includes some less covered stocks because of the impact from the news flow today.  We are seeing shares moving in Aeterna Zentaris Inc. (NASDAQ:...
Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend.  We are focusing solely on the biotech,...
These are this Thursday morning’s top pre-market day trader alert and active trader alert stocks moving on unusual trading volume.  We have a link through to more color and analysis on price...